Related references
Note: Only part of the references are listed.MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study
Jasper M. Morrow et al.
LANCET NEUROLOGY (2016)
Targeting protein homeostasis in sporadic inclusion body myositis
Mhoriam Ahmed et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken
Olivier Benveniste et al.
ACTA NEUROPATHOLOGICA (2015)
Rapamycin and Chloroquine: The In Vitro and In Vivo Effects of Autophagy-Modifying Drugs Show Promising Results in Valosin Containing Protein Multisystem Proteinopathy
Angele Nalbandian et al.
PLOS ONE (2015)
Evaluation and construction of diagnostic criteria for inclusion body myositis
Thomas E. Lloyd et al.
NEUROLOGY (2014)
Treatment of sporadic inclusion body myositis with bimagrumab
Anthony A. Amato et al.
NEUROLOGY (2014)
mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy
James K. Ching et al.
HUMAN MOLECULAR GENETICS (2013)
Share Paper
